Tip Card: Bispecific Therapy

Bispecific antibody therapies are a combination of two immunotherapy approaches in one drug. Bispecifics are comprised of two monoclonal antibodies that bind to two different antigens and trigger the immune system to destroy the patient’s myeloma cells.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.